PIK3CA oncogenic mutations in neoadjuvant treatments for breast cancer

Biomark Med. 2017 Jul;11(7):519-521. doi: 10.2217/bmm-2017-0048. Epub 2017 Jul 12.
No abstract available

Keywords: PIK3CA oncogenic mutation; breast cancer; neoadjuvant treatment.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Breast Neoplasms / genetics*
  • Class I Phosphatidylinositol 3-Kinases / genetics*
  • Female
  • Humans
  • Mutation / genetics
  • Neoadjuvant Therapy

Substances

  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CA protein, human